Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. Januar 2019 16:00 ET | Quelle: B. Braun CeGaT, LLC

CeGaT receives California CLIA State License and Accreditation - expanding diagnostic services in California

BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare &...
29. April 2015 10:58 ET | Quelle: B. Braun CeGaT, LLC

B. Braun CeGaT to Present Scientific Findings During an Exhibitor Presentation and Poster Session at the 2015 ARVO Annual Meeting; Will Highlight the Comprehensive Genomic Testing Services and Major Milestone of 1,000 Patient Samples Tested for Eye Diseases

BETHLEHEM, Pa., April 29, 2015 (GLOBE NEWSWIRE) -- Braun CeGaT, a molecular diagnostics service provider with extensive experience in the area of hereditary eye diseases, will be exhibiting at the...
15. April 2015 11:11 ET | Quelle: B. Braun CeGaT, LLC

B. Braun CeGaT Surpasses Milestone of 1,000 Patient Samples Tested for Neuromuscular and 500 for Neurodegenerative Diseases; Will Introduce Comprehensive Genomic Testing Services for Neurodegenerative Diseases at the 2015 American Academy of Neurology (AAN) Annual Meeting

BETHLEHEM, Pa., April 15, 2015 (GLOBE NEWSWIRE) -- B. Braun CeGaT, a molecular diagnostics service provider with extensive experience in the area of neurological diseases (e.g. neuromuscular and...
04. Dezember 2014 16:12 ET | Quelle: B. Braun CeGaT, LLC

B. Braun CeGaT Surpasses Milestone of 2000 Patient Samples Tested for Epilepsies, Will Introduce Comprehensive Genomic Testing Services for Epilepsies and Migraines at the 2014 American Epilepsy Society (AES) Annual Meeting

BETHLEHEM, Pa., Dec. 4, 2014 (GLOBE NEWSWIRE) -- B. Braun CeGaT, a molecular diagnostics service provider with extensive experience in the area of epilepsy, will be exhibiting at the 68th Annual AES...
19. November 2014 12:50 ET | Quelle: B. Braun CeGaT, LLC

CeGaT Wins Second Place in the 2014 Technology Fast 50 Award Competition

BETHLEHEM, Pa., Nov. 19, 2014 (GLOBE NEWSWIRE) -- CeGaT has been awarded second place in Deloitte's Technology Fast 50 Award business competition. Yesterday Managing Director Dr. Dirk Biskup accepted...
01. Juli 2014 17:06 ET | Quelle: B. Braun CeGaT, LLC

CeGaT Selects N-of-One to Provide Clinical Interpretation for Next-Generation Sequencing Tests

BETHLEHEM, Pa., July 1, 2014 (GLOBE NEWSWIRE) -- CeGaT, a leading, innovative laboratory that provides a wide array of molecular diagnostics tests, has announced an agreement with N-of-One, Inc., the...
04. Juni 2014 12:37 ET | Quelle: B. Braun CeGaT, LLC

B Braun Medical US and CeGaT Enter US Sequencing and Diagnostics Market With a Wide Range of Diagnostic Panels Including Tumor Diagnostics, Neuromuscular Diseases and Epilepsy

BETHLEHEM, Pa., June 4, 2014 (GLOBE NEWSWIRE) -- B Braun Medical US and CeGaT GmbH today announce the establishment of a US based company to enter the US diagnostics market. Globally, Diagnostic...